Capricor Therapeutics, Inc.

Capricor (NASDAQ: CAPR) is a biotechnology company developing cell and exosome-based therapeutics for serious diseases.

General Information
Company Name
Capricor Therapeutics, Inc.
Founded Year
2005
Location (Offices)
San Diego, United States +1
Founders / Decision Makers
Number of Employees
137
Industries
-
Funding Stage
-
Social Media

Capricor Therapeutics, Inc. - Company Profile

Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy, which results in muscle degeneration and premature death. Capricor’s innovative exosome technology is focusing on engineering exosomes to treat or prevent diseases with high unmet medical needs. Our translational approach to product development is based on the strong research foundation provided by our academic partnerships with leading scientists at top-tier research institutions.

Funding Rounds & Investors of Capricor Therapeutics, Inc. (0)

View All

There is no investment information

Latest News of Capricor Therapeutics, Inc.

View All

No recent news or press coverage available for Capricor Therapeutics, Inc..

Similar Companies to Capricor Therapeutics, Inc.

View All
Muscular Dystrophy Association - Similar company to Capricor Therapeutics, Inc.
Muscular Dystrophy Association Faster breakthroughs, Stronger futures.
Genea Biocells US, Inc. - Similar company to Capricor Therapeutics, Inc.
Genea Biocells US, Inc. Strength In Discovery
Somite Therapeutics - Similar company to Capricor Therapeutics, Inc.
Somite Therapeutics Redefining Cell Therapy with Artificial Intelligence
BreStem Therapeutics, Inc. - Similar company to Capricor Therapeutics, Inc.
BreStem Therapeutics, Inc. BreStem is a clinical stage biotech company working to fight deadly lung diseases through stem cell & exosome therapies.
Elixirgen Therapeutics, Inc. - Similar company to Capricor Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Reimagine the Power of RNA